Advisors Asset Management, Inc.
Position in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 1297376
Monument, CO
Position in CPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,399,926
+$218,169 QoQ
Shares Held
177,703
-0.8% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Advisors Asset Management, Inc. holds $38,396,219 across 40 Biotechnology names. CPRX ranks #2 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,300 | $10,850,922 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
This page
|
177,703 | $4,399,926 | |
| 3 | ASND |
Ascendis Pharma A/S
|
12,200 | $2,790,506 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,085 | $2,383,594 | |
| 5 | INCY |
Incyte Corp
|
21,594 | $2,032,427 | |
| 6 | ARQT |
Arcutis Biotherapeutics, Inc.
|
79,116 | $1,863,972 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
18,718 | $1,627,904 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
6,948 | $1,387,168 |
All Filings in CPRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,399,926 | 177,703 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,181,757 | 179,167 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,795,165 | 192,648 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $4,155,897 | 191,516 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,337,500 | 178,866 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,465,400 | 166,047 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,525,380 | 177,333 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,569,001 | 165,849 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,587,695 | 225,075 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,370,405 | 200,500 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,728,876 | 318,980 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,332,437 | 322,354 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,284,841 | 318,748 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,911,879 | 317,843 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,222,806 | 251,193 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,742,139 | 248,522 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,117,317 | 134,779 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $297,602 | 43,959 | Shares | Sole | 2022-02-15 | |
| No filing history on record for this holder in this stock. | ||||||